2'-F-N2-ibu-2'-ara-dG manufacturers
|
| | 2'-F-N2-ibu-2'-ara-dG Basic information |
| Product Name: | 2'-F-N2-ibu-2'-ara-dG | | Synonyms: | 2'-F-N2-ibu-2'-ara-dG;N2-iso-Butyroyl-2'-fluoro-2'-deoxyarabinoguanosine;Propanamide, N-[9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methyl-;N2-Isobutyryl-2'-FANA-2'-deoxyguanosine;N2-isobutyryl-2’-Deoxy-2’-fluoro-beta-D-arabinoguanosine;N2-iso-Butyroyl-2’-fluoro-2’-deoxyarabinoguanosine | | CAS: | 308356-20-9 | | MF: | C14H18FN5O5 | | MW: | 355.33 | | EINECS: | | | Product Categories: | | | Mol File: | 308356-20-9.mol |  |
| | 2'-F-N2-ibu-2'-ara-dG Chemical Properties |
| density | 1.78±0.1 g/cm3(Predicted) | | pka | 8.68±0.20(Predicted) |
| | 2'-F-N2-ibu-2'-ara-dG Usage And Synthesis |
| Uses | N2-iso-Butyroyl-2’-fluoro-2’-deoxyarabinoguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-F-N2-ibu-2'-ara-dG Preparation Products And Raw materials |
|